Full Value of Vaccines Assessments (FVVA), a new framework for assessing and communicating the value of vaccines published in BMC Medicine

A new framework aiming to guide the assessment and communication of the broader value of a vaccine has just been published in BMC Medicine. The Full Value of Vaccines Assessments (FVVA) framework is designed to facilitate alignment across key stakeholders and to enhance decision-making around investment in vaccine development, policy-making, procurement, and introduction, particularly for vaccines intended for use in low- and middle-income countries

The FVVA framework has three key elements:

• Enhance assessment, existing value-assessment methods and tools are adapted to include broader health and socio-economic benefits of vaccines as well as opportunity costs borne by stakeholders.
• To improve decision-making, a deliberative process is required to recognize the agency of stakeholders and to ensure country ownership of decision-making and priority setting.
• Providing a consistent and evidence-based approach that facilitates communication about the full value of vaccines, helping to enhance alignment and coordination across diverse stakeholders